Registry to monitor malnutrition in cancer patients
Official title: Multicentric, Observational, Longitudinal Study for the Evaluation of Nutritional Management Implications in Newly Diagnosed Italian Cancer Patients: The Italian Registry of Malnutrition in Oncology (IRMO)
Run by Fondazione IRCCS Policlinico San Matteo di Pavia · NCT06337019 · Data updated 2026-11-12
This study is trying to see how tracking nutrition in newly diagnosed or treated cancer patients can help improve their health and quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1500 (estimated) |
| Sponsor | Fondazione IRCCS Policlinico San Matteo di Pavia Academic / other |
| Locations | 16 sites (Bari, BA and 15 other locations) |
| Status | Recruiting |
| Started | October 25, 2022 |
| Main results expected | October 2027 |
| Study ends | October 2027 |
| Registry record updated | April 3, 2024 |
| Trial ID | NCT06337019 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with a new diagnosis of specific cancers who are eligible for active treatment.
✕Probably not a fit
Patients who are unable to undertake the expected measurements or guarantee attendance at follow-up visits may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Italian Registry of Malnutrition in Oncology (IRMO) aims to create a digital register for newly diagnosed or treated cancer patients to monitor their nutritional status and identify malnutrition early. This multicentric longitudinal observational study will collect real-world clinical data on malnutrition in oncology across Italy, focusing on its implications for overall survival and quality of life. By establishing a prospective cohort, the study seeks to improve nutritional care practices and management for cancer patients undergoing active treatment.
Why it matters
Potential benefit: If successful, this study could lead to improved nutritional support and management for cancer patients, potentially enhancing their survival and quality of life.
How similar studies have gone: While this approach is focused on collecting real-world data, similar studies have shown that improved nutritional management can positively impact cancer patient outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged ≥18 years; * New diagnosis of the following cancers: head and neck, oesophagus/stomach, colorectal, hepato-biliary, pancreatic, lung, prostate, other urogenital, breast, gynaecological and, soft tissue sarcomas and melanomas; patients with a new diagnosis of metastatic disease will be also included; * Eligible for active treatment; * Written informed consent to participate in the study. Exclusion Criteria: * Impossibility to undertake the expected measurements; * Impossibility to guarantee the attendance of the follow-up visits.
Where it's running
-
IRCCS Saverio De Bellis
Castellana Grotte, Ba, Italy Recruiting -
Istituto Ortopedico Rizzoli
Bologna, Bo, Italy Recruiting -
Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" IRCCS
Meldola, Fc, Italy Recruiting -
IRCCS Ospedale San Raffaele, Milano
Milan, Mi, Italy Recruiting -
Centro di Riferimento Oncologico
Aviano, Pn, Italy Recruiting -
IOV Istituto Oncologico Veneto
Padova, Pv, Italy Recruiting
Show 10 more locations
-
AUSL IRCCS Reggio-Emilia
Reggio Emilia, Re, Italy Recruiting -
IDI IRCCS - Istituto Dermopatico dell'Immacolata
Roma, Rm, Italy Recruiting -
Istituto Nazionale Tumori Regina Elena
Roma, Rm, Italy Recruiting -
Policlinico Universitario Agostino Gemelli
Roma, Rm, Italy Recruiting -
Istituto di Candiolo - Fondazione del Piemonte per l'Oncologia - IRCCS
Candiolo, To, Italy Recruiting -
IRCCS Sacro Cuore Don Calabria
Negrar, Vr, Italy Recruiting -
Fondazione IRCCS Policlinico San Matteo, Pavia
Pavia, Italy Recruiting -
IRCCS Istituto Tumori Giovanni Paolo II,
Bari, Ba, Italy Not yet recruiting -
IRCCS Ospedale Policlinico San Martino
Genova, Ge, Italy Not yet recruiting -
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale
Naples, Italy Not yet recruiting
Study contacts
- Study coordinator: Riccardo Caccialanza
- Email: r.caccialanza@smatteo.pv.it
- Phone: +39 0382501615
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
IL-22BP mRNA peptide therapy for advanced solid tumors
A phase 1 study tests a new peptide-delivered IL-22BP mRNA treatment to see if it is safe and if it has any early signs of shrinking or stopping advanced solid tumors in adults.
-
Symptom Management and Survivorship Coaching for Advanced Cancer Patients and Caregivers
This study tests a 10-week Symptom Management and Survivorship Handbook plus telephone coaching to help metastatic cancer patients and their caregivers manage symptoms and stay connected.
-
Comparing two types of radiation therapy for painful bone metastases
This study is testing whether a new type of radiation therapy can help people with painful bone cancer feel better than the standard treatment.
-
Testing the safety and dosing of zeaxanthin for advanced cancer treatment
This study is testing how much zeaxanthin, a natural compound, can be safely given to people with advanced cancer to see if it helps them without causing bad side effects.
-
Registry for childhood and young adult cancer patients
This study is creating a registry for young cancer patients to track their health and well-being over time and help improve future care.
-
Using IlluminOss implants to treat pelvic fractures in cancer patients
This study is testing if IlluminOss implants can help cancer patients with pelvic fractures feel less pain and improve their daily activities.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.